Delayed quote: Aug 4, 2026, 9:45 AM EDT
Revenue · 5YDoes not currently clear the 15%+, 20%+, or 30%+ revenue bars over 5Y.
No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 0.1x · 10Y median 0.2x · 31st percentile · as of Aug 3, 2026
Annual revenue · last 8 fiscal years
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
The latest delayed quote for Petco Health and Wellness Company, Inc. (WOOF) stock was $2.91 as of Aug 4, 2026, 9:45 AM EDT, down 0.17% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -0.3% · 3-year avg -27.5%/yr · 5-year avg -31.7%/yr
Petco Health and Wellness Company, Inc. operates as an enterprise focused on enhancing the well-being of companion animals, their human guardians, and its own associates.
How WOOF’s revenue breaks down across its reported segments in the latest reported fiscal year.
Next Earnings Date
Aug 27, 2026
23 days away
EPS Estimate
0.06
Revenue Est.
$1.49B
Last Quarter Results
EPS
$0.03
vs Estimate
$0.03
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1WOOF | $829.57M | $2.90 | -0.17% | -0.34% | -31.69% | N/A | N/A |
| 2LQDT | $1.23B | $39.29 | -0.03% | +66.97% | +14.28% | +17.01% | vs WOOF |
| 3CRI | $1.43B | $38.81 | -2.68% | +73.56% | -13.87% | -6.20% | vs WOOF |
| 4MSC | $91.48M | $1.90 | +1.06% | -60.24% | -28.52% | N/A | vs WOOF |
| 5KSS | $2.23B | $19.70 | -1.99% | +92.66% | -11.75% | -1.36% | vs WOOF |
| 6BKE | $2.36B | $45.83 | -0.63% | -4.33% | +11.18% | +16.04% | vs WOOF |
Shares are of reported segments and may not sum to total company revenue.
$1.50B
vs Estimate
$1.49B
Consensus Rating
Based on 11 analysts
Average Price Target
$3.54
+22.0% upside
Low
$2.34
Current
$2.90
High
$5.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Aug 2026 | $0.06 | $0.07 | $0.08 | 5 |
| Quarter ending Nov 2026 | $0.05 | $0.05 | $0.05 | 4 |
| Quarter ending Feb 2027 | $0.07 | $0.07 | $0.07 | 1 |
| Quarter ending May 2027 | $0.04 | $0.04 | $0.04 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $0.19 | $0.20 | $0.21 | 5 |
| FY 2028 | $0.23 | $0.25 | $0.26 | 5 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Aug 2026 | $1.49B | $1.49B | $1.50B | 5 |
| Quarter ending Nov 2026 | $1.48B | $1.48B | $1.48B | 5 |
| Quarter ending Feb 2027 | $1.53B | $1.53B | $1.53B | 2 |
| Quarter ending May 2027 | $1.51B | $1.51B | $1.52B | 2 |
Annual
| Period | Low |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the next-fiscal-year consensus EPS estimate (the same value shown in the Key Metrics strip).
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2027 | $5.92B | $6.00B | $6.04B | 8 |
| FY 2028 | $6.00B | $6.07B | $6.12B | 8 |
